Form 8-K - Current report:
SEC Accession No. 0001493152-22-018233
Filing Date
2022-06-30
Accepted
2022-06-30 16:05:25
Documents
12
Period of Report
2022-06-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35193
  Complete submission text file 0001493152-22-018233.txt   207117

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocx-20220624.xsd EX-101.SCH 2956
3 XBRL LABEL FILE ocx-20220624_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ocx-20220624_pre.xml EX-101.PRE 22358
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3570
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 221058061
SIC: 2835 In Vitro & In Vivo Diagnostic Substances